Renaissance Technologies’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78.8K | Buy |
+26,100
| New | +$78.8K | ﹤0.01% | 3335 |
|
|
2024
Q3 | – | Sell |
-10,418
| Closed | -$30.7K | – | 3779 |
|
|
2024
Q2 | $30.7K | Sell |
10,418
-1,800
| -15% | -$5.31K | ﹤0.01% | 3339 |
|
|
2024
Q1 | $36K | Sell |
12,218
-500
| -4% | -$1.47K | ﹤0.01% | 3531 |
|
|
2023
Q4 | $32K | Buy |
12,718
+500
| +4% | +$1.26K | ﹤0.01% | 3522 |
|
|
2023
Q3 | $38K | Buy |
12,218
+5,313
| +77% | +$16.5K | ﹤0.01% | 3441 |
|
|
2023
Q2 | $32K | Buy |
6,905
+3,925
| +132% | +$18.2K | ﹤0.01% | 3693 |
|
|
2023
Q1 | $21K | Buy |
2,980
+1,570
| +111% | +$11.1K | ﹤0.01% | 3815 |
|
|
2022
Q4 | $9K | Buy |
+1,410
| New | +$9K | ﹤0.01% | 4040 |
|
|
2022
Q2 | – | Sell |
-7,873
| Closed | -$235K | – | 4466 |
|
|
2022
Q1 | $235K | Sell |
7,873
-522
| -6% | -$15.6K | ﹤0.01% | 3581 |
|
|
2021
Q4 | $364K | Buy |
8,395
+5,550
| +195% | +$241K | ﹤0.01% | 3249 |
|
|
2021
Q3 | $203K | Sell |
2,845
-935
| -25% | -$66.7K | ﹤0.01% | 3202 |
|
|
2021
Q2 | $434K | Sell |
3,780
-1,735
| -31% | -$199K | ﹤0.01% | 3014 |
|
|
2021
Q1 | $572K | Buy |
+5,515
| New | +$572K | ﹤0.01% | 2860 |
|
|
2020
Q3 | – | Sell |
-3,735
| Closed | -$143K | – | 3589 |
|
|
2020
Q2 | $143K | Buy |
+3,735
| New | +$143K | ﹤0.01% | 3219 |
|
|
2019
Q2 | – | Sell |
-6,810
| Closed | -$538K | – | 3705 |
|
|
2019
Q1 | $538K | Buy |
+6,810
| New | +$538K | ﹤0.01% | 2900 |
|